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Introduction 
Human immunodeficiency virus (HIV) infection is one of the main global health problems and becomes a risk factor for tuberculosis.1,2 The 
characteristics of immunological effect of HIV is the CD4 cell count.2 People with HIV infection 
also have a higher risk to get all types of extra 
pulmonary tuberculosis, including tuberculous 
meningitis (TBM).3 Tuberculous meningitis is the most common cause of meningitis in 
HIV-infected people along with cryptococcus meningitis.4,5 Meningitis is considered as the worst manifestation of tuberculosis.6,7 Their combined appearance makes diagnosis and 
treatment challenging due to the unspecific and similar clinical manifestations to other causes of chronic meningoencephalitis and also 
because it is necessary to provide treatment for both infections and their complication.8Knowledge on hematological manifestation 
of Mycobacterium tuberculosis (Mtb) infection 
is important to provide knowledge on the pathogenesis of the disease.9 Myeloid-specific 
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cells have been known as the host cells for Mtb 
growth and lymphoid cells are known as the 
main effector cells in tuberculosis immunity.9,10 
The main role of monocytes and lymphocytes in inducing that immune response makes its 
level in Monocytes to Lymphocyte (ML) ratio 
is expected to be able to reflect the person’s immune condition toward the infection.9
Study on patients with active tuberculosis showed that a higher median absolute number 
of monocytes and a lower median absolute 
number of lymphocytes were observed among 
these patients when compared to the healthy controls.9 Hence, ML ratio could be used to 
differentiate patients with active tuberculosis 
from healthy people.9 A retrospective study on 
patients with active tuberculosis showed that 
higher or lower ML ratio based on a predefined 
cut-off could be a significant predictor for active tuberculosis.9 Patients with extra pulmonary 
tuberculosis had an ML ratio as high as almost 2.5 times higher compared to the normal group.9 Many studies showed that the ML ratio 
could be used to stratify tuberculosis risks 
and the involvement of hematopoietic stem-
cell in tuberculosis pathogenesis among HIV-infected people.10 Therefore, ML ratio could be used as an independent prognostic marker 
and a marker of a successful anti-tuberculosis 
therapy.11Screening and diagnostic testing of TBM in 
Dr. Hasan Sadikin General Hospital Bandung 
still face several challenges: complicated  TBM 
examination algorithm, expensive diagnostic tests, low economic status of  the patients, lack 
of education, etc. Due to these difficulties in 
diagnosing TBM with HIV co-infection, studies related to a simple detection or screening tool for TBM need to be done.5,7 The objectives 
of this study was to describe the ratio of 
monocytes to lymphocytes in peripheral blood 
as a predictor for TBM with HIV infection to 
seek the possibility to use the ratio as an additional tool for the clinician to perform the diagnostic algorithm of TBM.
Methods
This was a cross-sectional study using TBM 
retrospective clinical-based data. Population 
of this study consisted of TBM patients  who 
were hospitalized in Dr Hasan Sadikin General Hospital Bandung during the period of 2014–2016. The inclusion criteria included patients 
aged 18 years old or above diagnosed with TBM based on the diagnostic criteria from Marais 
et al.7 and had performed the first laboratory 
examination (hematology, immunology and 
cerebrospinal fluid (CSF) examination) after being diagnosed TBM with complete data. 
Patients with any missing data were excluded 
from this study.
Patients were divided into 4 groups based 
on the diagnostic criteria stated by Marais 
et al.7 The criteria were definite tuberculous meningitis, probable tuberculous meningitis, possible tuberculous meningitis, and not tuberculous meningitis. The description on the components of these criteria and the scoring 
procedure is available elsewhere. 
This study used total sampling collection method, of which all members of the population 
were recruited in the study. All data regarding hospitalized TBM patients were collected from the medical record database of Department of 
Neurology, Dr. Hasan Sadikin General Hospital Bandung during the period of 2014–2016. 
Those who fulfilled the inclusion criteria were 
included in the analysis.The data collection process was performed 
in 2 places: Department of Neurology and Medical Record Unit of Dr. Hasan Sadikin 
General Hospital Bandung. Data that were 
collected  included  data on patients’ general characteristics, clinical manifestations, and 
laboratory results. Data collected were also 
double-checked for correctness with data on 
routine hematology with differential count 
and CSF examination from the Department of 
Clinical Pathology, Dr. Hasan Sadikin General Hospital, Bandung. Data collected were then 
merged in a prepared database for analysis.
Two hundred and eighty patients met the 
inclusion criteria of this study. Of these, 195 
were excluded due to incomplete data: absent of differential count test, no lumbar puncture 
was performed, or no HIV testing was done. 
The flowchart of this study was summarized in the diagram (Fig. 1).
This study was approved by the Health 
Research Ethic Committee of the Faculty of 
Medicine, Universitas Padjadjaran and from the Research Education Unit of Dr. Hasan 
Sadikin General Hospital, Bandung. 
Patients’ data consisted of name, gender, 
age, diagnosis, HIV status, result of routine hematological tests and differential count,  and 
results of CSF examination were collected and 
entered into a pre-prepared database (Excel software, Microsoft Corp.). All data were processed and presented using percentage in a table to describe the gender, age group, 
clinical manifestation, CSF analysis, and ML 
ratio. The ML ratios were tabulated based on 
the HIV status and patient’s TBM diagnosis, 
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which were divided into possible, probable, 
and definite TBM. The ML ratios were then 
classified and presented in percentiles: (1) 
≤25th percentile ML ratio of all patients (ML 
ratio ≤0.47), (2) between 25th–75th percentile 
(0.47<ML ratio<1.22), (3) ≥75th percentile 
ML ratio of all patients (ML ratio ≥1.22).9 A bar 
chart was used to present the ML ratio in the 
population. All the data were analyzed using 
STATA version 12.0 (Stata Corp., Texas, USA).
Results
In the population of this study, 15 patients 
(18%) were diagnosed as suffering from TBM 
with HIV- positive and 70 patients (82%) 
with HIV negative. Among the TBM with HIV 
positive population, male patients were more 
dominant (87%) as well as the 25–34 years old 
age group 47%). This finding is similar with the 
finding in a study performed by from Afriandi 
et al.12 in 2009 that described the national 
AIDS cases were dominated by males (75%) 
with 42% were reported to be IDU-related. 
Heterosexual and homosexual transmission 
was 48% and 3.7%, respectively. Most cases 
found in this study were classified as probable 
TBM (63.5%) in accordance with diagnostic criteria from Marais et al.7 This  number was 
followed by possible TBM (34.1%) and then 
definite TBM (2.4%) categories. The four most 
commonly identified clinical manifestations 
were headache, neck stiffness, fever, as well 
as decreased level of consciousness. Results 
of CSF examination showed that there was a process of meningeal irritation, which was 
proven by high number of leukocyte count (>5 cells/mm3), low CSF-serum glucose ratio 
(<50%), and high level of protein (>50 mg/
dL) in most subjects. The median of ML Ratio 
among HIV positive patients was 0.81 while 
the HIV negative patients had a ratio of 0.67 (Table 1).
In TBM with HIV positive population, there 
were 6 subjects who had an ML ratio of 0.47 
and 3 with an ML ratio of 1.22. In TBM with 
HIV negative population, 16 subjects had an 
ML ratio of 0.47 and 19 had an ML ratio of 1.22.
Discussion
Hematological changes could be used as the first hallmark of a disease process as radiological 
changes and physical signs often appear later.13 
Monocyte is among the important components of innate immune response that act as a link 
to the adaptive immune system by presenting 
antigen to lymphocyte.9 Hence, any factor that 
influences the function or relative number of 
both cells could potentially affect individual’s response toward infection.9
Peripheral blood monocyte to lymphocyte 
ratio could reflects an individual’s capacity to 
mount effective immune responses.9 This ratio 
has been found to correlate with Mycobacterial 
in vitro growth inhibition and is  considered 
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a risk if found in person with high or low ML 
ratio, based on the percentile cut-off.9,14 It has been reported that Mtb infection could disturb 
hematopoietic stem cells or may directly infect 
the bone marrow mesenchymal stem cells.9,15 
Studies in mice and human have shown that hematopoietic stem cells present a different 
ratio of myeloid to lymphoid cells they will give rise to.9,16,17 Different proportions of myeloid 
hematopoietic stem cells or lymphoid could 
lead to the difference of ML ratio in peripheral 
blood.9 Hence, it is probable that Mtb infection could affect hematopoietic stem cells as well 
as the ML ratio being affected.9
Most subjects in this study were found to 
have lymphopenia. This is similar to a previous 
study by Okamura et al.18 Lymphopenia might 
occur due to the accumulation of lymphocytes in the infection sites, leading to a decrease in 
the number of lymphocites in the peripheral blood.11,19 For monocytes, most patients have 
normal or high monocyte count (monocytosis).
Table 1 Characteristic, Clinical Manifestation, Labolatory Examination of Study Subjects
Variable HIV Positive (n=15) HIV Negative (n=70)
Gender   Female 2 (13%) 25 (36%)   Male 13 (87%) 45 (64%)
Age group, years   18–24 3 (20%) 22 (31%)   25–34 7 (47%) 25 (36%)   35–49 5 (33%) 15 (21%)   >49 0 (0%) 8 (11%)Tuberculous meningitis   Possible 5 (33%) 24 (34%)   Probable 9 (60%) 45 (64%)
   Definite 1 (7%) 1 (1%)Clinical presentation, N
   Decrease of level of consciousness 13 (87%) 61 (87%)   Neck stiffness 12 (80%) 65 (93%)   Headache 13 (87%) 66 (94%)
   Fever 12 (80%) 61 (87%)
   Vomiting 5 (33%) 21 (30%)   Seizure 2 (13%) 5 (7%)
CSF analysis, N
   Leukocyte count >5 cells/mm3 10 (67%) 66 (94%)
   Glucose ratio <50% 13 (87%) 61 (87%)
   Protein >50 mg/dL 11 (73%) 64 (91%)
Hematology cell-count, median (range)
   Lymphocyte count, median (range), % 13 (4–56) 8 (2–47)
   Monocyte count, median (range) % 8 (4–15) 6 (1–21)
   Monocyte to lymphocyte ratio, median (range) 0.81 (0.13–2.80) 0.67 (0.03–1.62)
Data presented as n (%) unless there was another explanation mentioned.
Abbreviation: CSF= cerebrospinal fluid; HIV= human immunodeficiency virus
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 Monocytosis might occur because monocyte 
have a role in phagocytosis of microorganism.20 
Microorganisms which successfully escape the immune response cause infection and produce 
chemo attractant substances that will invite 
other leukocytes and resulting in unopposed 
production of monocytes.20 This creates a 
different ML ratio in patients when compared 
with healthy people.
Monocyte to lymphocyte ratio is a simple 
tools that is expected to reflect the person’s immune condition toward the infection. The 
normal average of ML ratio is 0.3.19 The TBM 
with HIV negative patients in this study had a 
higher ML ratio. The majority of the subjects 
have an ML ratio of more than 0.47 (>25th 
percentile). This is similar to the finding in a 
previous study by Wang et al.9 with increased 
ML ratio among active tuberculosis and extra 
pulmonary tuberculosis patients and a lower 
or higher ML ratio can predict the presence of 
active tuberculosis. In TBM with HIV positive 
a higher ML ratio was also seen while some 
subjects had a lower ML ratio (less than or 
equals 0.47). This is similar to a previous study 
with HIV patients as the subjects by Naranbhai 
et al.10 that showed tuberculosis is higher in 
HIV patients with lower or higher ML ratio. 
This situation might be explained by immune 
response toward Mtb. Myeloid-specific cells 
have been known to have role as host cells for 
Mtb growth and lymphoid cells as the main 
effector in TB immunity.9,10 Therefore, most of 
the TBM subjects in this study have higher ML 
ratio. Within this  study, any clear distinguish 
of ML ratio among each group was not found 
and further comprehensive study is needed to 
analyze. Overall, the results of this current study 
gives evidence for supporting the correlation 
between immunity and tuberculosis as well as 
extra pulmonary tuberculosis, as described in 
previous study. Hence, ML ratio could be used 
as a tool for detecting active TBM, either with 
or without HIV infection.
This study has several limitations. This was 
retrospective study used data from medical record database. Since the diagnosis was made using Marais criteria, there might be a slight difference among clinicians when establishing the TBM diagnosis. Despite the limitations, 
this study supports the notion that ML ratio is disrupted in TBM population with or without 
HIV infection as already mentioned in  several 
previous studies. However, a prospective study using dedicated population and sample size 
need to be done to find the actual correlation 
between ML ratio and TBM.
This study shows that the ML ratio in TBM 
patients with HIV infection at Dr. Hasan Sadikin 
General Hospital, Bandung can be used as an 
additional tool for detecting the  development 
of TBM in patients with HIV as well as in non-
HIV-infected patients. Therefore, it could help to direct the patients with clinical suspicion of TBM into TBM diagnosis algorithm and treatment and to a better disease outcome. The 
results of this study can also be used to create 
an evidence based-medicine approach in Dr. 
Hasan Sadikin General Hospital, Bandung as a 
teaching hospital and tertiary hospital in West 
Java, Indonesia.
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